Results 181 to 190 of about 29,547 (250)

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. [PDF]

Ann Transplant
Jeong IJ, Hwang S, Ahn CS, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Kang WH, Yoon YI, Lee SG.   +10 more
europepmc   +1 more source

Parthenolide inhibits the progression of intrahepatic cholangiocarcinoma by promoting ferroptosis through inhibiting UBD. [PDF]

Cancer Biol Ther
Xie Y, Wang J, Zhou J, Peng Y, Wang Y, Wang Y, Song Y.   +6 more
europepmc   +1 more source

Cancer-Associated Fibroblasts in the Treatment of Intrahepatic Cholangiocarcinoma: Present and Prospects. [PDF]

J Hepatocell Carcinoma
Yuan Y, Zhang R, Qu C, Huang N, Wang L, Liu M.   +5 more
europepmc   +1 more source

Clinical efficacy of HAIC combined with TACE in patients with unresectable intrahepatic cholangiocarcinoma. [PDF]

BMC Cancer
Wan J, Jin C, Fan Z, Yu C, Li C, Jin X, Zhou Y, Tang B, Qu X.   +8 more
europepmc   +1 more source

Recent advances in molecular classification and multimodal treatment of intrahepatic cholangiocarcinoma. [PDF]

World J Surg Oncol
Saboor F, Lu J.
europepmc   +1 more source

ASO Author Reflections: From Recommendation to Reality: Expert Multidisciplinary Collaboration in Intrahepatic Cholangiocarcinoma Care. [PDF]

Ann Surg Oncol
Zwaan TC, Buettner S, Groot Koerkamp B, Olthof PB, Dutch Hepatocellular and Cholangiocarcinoma Group.   +4 more
europepmc   +1 more source

IGF2BP2 Overexpression Predicts Poor Prognosis and Correlates with PD-L1 Expression in Intrahepatic Cholangiocarcinoma. [PDF]

Biomedicines
Shen J, Yang A, He X, Dai T, Hui Z, Ding Y, Zhao L, Chen J.   +7 more
europepmc   +1 more source

A Dual-Gene Signature of PMAIP1 and GADD45A for Early Detection of Intrahepatic Cholangiocarcinoma in the Context of Primary Sclerosing Cholangitis. [PDF]

Int J Mol Sci
Yao B, Ma Y, Guan S, Zheng Q, Yu Y, Jia R, Shi Y, Hou Z, Wang Z, Liu J.   +9 more
europepmc   +1 more source

Relationships between immune cells, blood metabolites, and intrahepatic cholangiocarcinoma: a Mendelian randomization study with experimental validation. [PDF]

Front Cell Dev Biol
Ye Z, Tang B, Zhang Y, Chen H, Li J, Ye Z, Liu X, Li D.   +7 more
europepmc   +1 more source